Search
Redefining Sudden Cardiac Death
Zian H. Tseng, MD, discusses the conclusions of the UCSF Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death (POST SCD) Study.Hypertrophic Cardiomyopathy: Mostly Benign, Sometimes Lethal
Theodore Abraham, MD, discusses hypertrophic cardiomyopathy, a common inherited heart disease that is usually benign, but can be fatal in up to 10 percent of cases.Overview of Metagenomic Next-Generation Sequencing
Charles Chiu, MD, PhD, provides an overview of metagenomics next-generation sequencing (mNGS), a clinical test he and his UCSF colleagues have developed that allows millions of DNA sequences to be decoded from a single clinical sample.Clinical UCSF mNGS Assay for Diagnosis of Neurological Infections
Despite extensive conventional testing, acute neurological illness in hospitalized patients is difficult to diagnose. Charles Chiu, MD, PhD, discusses an mNGS test that identifies pathogens causing neurological infections from cerebrospinal fluid and how a recent multi-hospital study has demonstrated the clinical utility of this test.Clinical Case Reports and New mNGS-Based Technologies
Charles Chiu, MD, PhD, discusses cases where mNGS testing saved the life of a patient with undiagnosed neuroleptospirosis, and spared another patient from a potentially unnecessary liver transplant.Interstitial Lung Disease Program
Interstitial lung disease (ILD) patients at UCSF benefit from an internationally recognized team of ILD experts with the highest level of expertise in this rare and difficult-to-diagnose disease.UCSF Center for Next-Gen Precision Diagnostics
UCSF was the first in the world to provide metagenomic next-generation sequencing (mNGS) as a clinical test for diagnosis of neurological infections.Center for Limb Preservation and Diabetic Foot
The first and only dedicated amputation-prevention center in the Bay AreaPancreas Center
Novel therapeutics and state-of-the-art surgical techniques combined with an array of support services for patientsApproaches to Hematologic Cancers
Jeffrey Wolf, MD, director of the Myeloma Program at UCSF Health, discusses the traditional approaches to hematologic cancers.Approach to the Older Patient with Spinal Disorders: Surgery
Shane Burch, MD, MS, FRCSC, discusses surgical approaches for patients with spinal disorders including the various options to achieve decompression and realignment, stabilizing the patient and obtaining a fusion. The rationales behind these choices are also discussed.Approach to the Older Patient with Spinal Disorders: Diagnosis
Shane Burch, MD, MS, FRCSC, presents case examples of older patients with spinal disorders and focuses on approaches that are integral at arriving at an accurate diagnosis: patient history, physical examination and imaging, including X-ray, CT and MRI.Case Study: Multiple Myeloma and Novel Immunotherapy Approaches
Hematologist Nina Shah discusses the treatment plan of a patient diagnosed with a smoldering multiple myeloma (MM).Incorporating Clinical Trials Into Patient Care: A Unique Approach to Treating Head & Neck Cancer
With the advent of immunotherapy, UCSF physicians are incorporating clinical trials into head and neck cancer patient care and changing the treatment paradigm.UCSF Voice and Swallowing Center
Our fellowship-trained laryngologists and speech-language pathologists are voice and swallowing specialistsUCSF Liver Transplant Program
With high patient volumes and outstanding survival rates, UCSF Health is a leader in liver transplantationAwake Spine Surgery
Shorter surgeries result in decreased lengths of stay, faster recovery times and less reliance on narcoticsAdvanced Heart Failure Evaluation and Therapies Program
A full range of therapeutic options – including evidence-based pharmacology, innovative devices and an experienced transplant program – offer personalized approaches to slow progression, prolong survival and improve quality of lifeHematology and Blood and Marrow Transplant
Specialized treatments for acute and chronic blood conditions, from cancers to the full range of non-malignant blood disordersHead and Neck Surgical Oncology
Expert care to improve both survival and quality of lifeMelanoma and Skin Cancer Program
Highly specialized care for patients with melanoma, Merkel Cell and other skin cancersCAR-T Cell Therapy Treatment and Research
UCSF is a leader in the newest forms of cellular immunotherapy, which have been shown to be particularly effective in the treatment of B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (B-ALL).Breast Oncology
Expert care and transformative research working together to improve both survival and quality of lifeMinimally Invasive TLIF; Techniques and Outcomes
Aaron J. Clark, MD, PhD, describes the minimally invasive approaches of transforaminal lumbar interbody fusion (TLIF) and its advantages over open TLIF surgery including the benefits for the obese and elderly, fewer complications and less pain.